Both a biopsy method and a therapeutic procedure in BI-RADS 4A and 4B lesions: Ultrasound-guided vacuum-assisted breast biopsy.
BI-RADS
Ultrasound-guided
complication
treatment
vacuum-aspiration biopsy
Journal
Turkish journal of surgery
ISSN: 2564-6850
Titre abrégé: Turk J Surg
Pays: Turkey
ID NLM: 101704837
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
02
03
2019
accepted:
25
11
2019
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
This study aimed to evaluate outcomes, complications, and follow-up results of ultrasound-guided vacuum-assisted breast biopsy (UG-VABB) in BI-RADS 4 A and B lesions. Between Agust 2014 to January 2018, fifty BI-RADS 4A and BI-RADS 4B lesions of 41 patients biopsied with 10G vacuum needle by a single radiologist were retrospectively evaluated. All patients were females and mean age of the 41 patients was 50.12 ± 8.63. Of all lesions, 84% was benign, 6% was ADH, 4% was in-situ cancer, and 6% was diagnosed as malign. Follow-up duration after VABB was 0-51 months and mean was 20.92 months. Complications were as vasovagal-induced seizure in 3 patients (7.3%) and intramammary hematoma in 16 patients (39%). Hematoma was diagnosed in 3 patients (7.3%) at the 6th month follow-up and it was resolved in all patients at the 12th month follow-up. Higher breast density resulted in higher hematoma rates. There was no relationship between lesion BI-RADS subgroups, lesion size or sample number and hematoma development. During the follow-up, residue lesion in 1 (2.4%) patient and scar tissue in 2 (4.9%) patients was detected. US-guided VABB, with low complication rates and low scar development, is also a therapeutic excision method without remaining residue, which should be primarily preferred in smaller than 2 cm BI-RADS 4A and 4B lesions whose malignancy rates are relatively low. Hematoma, which is the most frequent complication, resorbed entirely in the 12th month in all patients.
Identifiants
pubmed: 32637878
doi: 10.5578/turkjsurg.4472
pmc: PMC7315444
doi:
Types de publication
Journal Article
Langues
eng
Pagination
65-71Informations de copyright
Copyright © 2020, Turkish Surgical Society.
Déclaration de conflit d'intérêts
Conflict of Interest: All authors declare no conflict of interest and financial relationships.
Références
Eur Radiol. 2016 Nov;26(11):3908-3916
pubmed: 26984430
Clin Radiol. 2010 Apr;65(4):259-70
pubmed: 20338392
J Breast Health. 2017 Apr 01;13(2):74-76
pubmed: 31244532
Eur Radiol. 2008 Sep;18(9):1761-73
pubmed: 18414872
J Ultrasound Med. 2012 Dec;31(12):1951-7
pubmed: 23197548
Radiology. 1998 Sep;208(3):717-23
pubmed: 9722851
Ultraschall Med. 2009 Feb;30(1):33-6
pubmed: 18773386
Ultrasonography. 2014 Oct;33(4):259-66
pubmed: 25036755
Korean J Radiol. 2005 Apr-Jun;6(2):102-9
pubmed: 15968149
Ir J Med Sci. 2018 Nov;187(4):999-1008
pubmed: 29549564
J Breast Cancer. 2011 Mar;14(1):1-7
pubmed: 21847387
Breast Cancer Res Treat. 2007 Mar;102(1):103-10
pubmed: 16838109
Chin Med Sci J. 2016 Mar 20;31(1):31-36
pubmed: 28031085
Ultrasonography. 2018 Jan;37(1):55-62
pubmed: 28641365
J Am Coll Surg. 2005 Jul;201(1):14-7
pubmed: 15978438
Radiology. 2000 Jun;215(3):694-7
pubmed: 10831686
Ultraschall Med. 2012 Aug;33(4):366-71
pubmed: 22723042
Clin Radiol. 2006 Jul;61(7):619-24
pubmed: 16784949